Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ)
CNY 12.14
(2.53%)
CNY 12.14
(2.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 263.44 Million | 227.37 Million | 257.56 Million | 257.18 Million | 83.01 Million | 91.23 Million |
| Net Income | -401.74 Million | -507.92 Million | -658.69 Million | 141.79 Million | 126.12 Million | 87.97 Million |
| Depreciation & Amortization | 237.29 Million | 242.29 Million | 149.91 Million | 135.32 Million | 114.77 Million | 114.2 Million |
| Deferred income taxes | 7.77 Million | -16.39 Million | 5.55 Million | 18.55 Million | -22.85 Million | -9.68 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -46.23 Million | 162.29 Million | 120.1 Million | -167.71 Million | -267.22 Million | -304.59 Million |
| Other non-cash items | 245.09 Million | 330.7 Million | 646.24 Million | 147.78 Million | 109.34 Million | 193.66 Million |
| Investing Cash Flow | -53.65 Million | 379.26 Million | -112.8 Million | -1.23 Billion | 848.17 Million | 219.63 Million |
| Investments in PPE | -56.03 Million | -367.26 Million | -562.73 Million | -707.41 Million | -661.09 Million | -495.46 Million |
| Acquisitions | 361.77 Thousand | 435.73 Million | -94.97 Million | 71.52 Million | 137.21 Million | 1.09 Billion |
| Investment purchases | -400 Thousand | -152.52 Million | -86.14 Million | -12.2 Million | -217.3 Million | -22.24 Million |
| Sales/Maturities of investments | 2.39 Million | 58.51 Million | 12.6 Million | 684.49 Thousand | 105.84 Million | 96.06 Million |
| Other Investing Activities | 18.53 Thousand | 404.8 Million | 618.44 Million | -591.13 Million | 1.48 Billion | -456.97 Million |
| Financing Cash Flow | -200.62 Million | -652.77 Million | -450.22 Million | 1.12 Billion | -1.03 Billion | -757.48 Million |
| Debt repayment | -59.91 Million | -1.05 Billion | -3.29 Billion | -2.21 Billion | -3.05 Billion | -2.37 Billion |
| Dividends payments | -140.65 Million | -175.8 Million | -216.91 Million | -31.33 Million | -21.28 Million | -207.38 Million |
| Common Stock Repurchased | - | -269.74 Thousand | -376.18 Thousand | - | - | - |
| Common Stock Issuance | - | 269.74 Thousand | 376.18 Thousand | - | - | - |
| Other Financing Activities | 15.9 Million | 579.84 Million | 3.06 Billion | 3.53 Billion | 2.26 Billion | 1.81 Billion |
| Accounts receivables | 62.88 Million | -106.32 Million | -14.74 Million | -491.11 Million | 1.07 Billion | -99.3 Million |
| Accounts payables | -126.51 Million | 266.37 Million | 86.44 Million | 388.24 Million | -1.15 Billion | 31.45 Million |
| Inventory | 9.61 Million | 18.65 Million | 42.85 Million | -83.4 Million | -160.43 Million | -87.84 Million |
| Other working capital | 17.1 Million | -16.39 Million | 5.55 Million | 18.55 Million | -22.85 Million | -216.75 Million |
| Cash at beginning of period | 126.37 Million | 171.6 Million | 477.16 Million | 333.94 Million | 434.01 Million | 878.67 Million |
| Cash at end of period | 135.52 Million | 126.37 Million | 171.6 Million | 477.08 Million | 333.94 Million | 434.01 Million |
| Capital Expenditure | -56.03 Million | -367.26 Million | -562.73 Million | -707.41 Million | -661.09 Million | -495.46 Million |
| Effect of forex changes on cash | -3601.53 | 901.04 Thousand | -92.12 Thousand | -380.88 Thousand | 188.09 Thousand | 1.94 Million |
| Net cash flow / Change in cash | 9.15 Million | -45.23 Million | -305.55 Million | 143.14 Million | -100.06 Million | -444.66 Million |
| Free Cash Flow | 207.4 Million | -139.89 Million | -305.17 Million | -450.23 Million | -578.07 Million | -404.22 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -82.57 Million | -99.56 Million | -35.65 Million | -242.89 Million | -401.74 Million | -80.07 Million |
| Depreciation & Amortization | - | 60.45 Million | 60.45 Million | 237.29 Million | 237.29 Million | -116.33 Million |
| Deferred income taxes | - | - | - | - | 7.77 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 89.61 Million | -46.23 Million | 39.85 Million |
| Other non-cash items | 53.04 Million | 127.56 Million | 61.47 Million | -12.54 Million | 245.09 Million | 195.98 Million |
| Investing Cash Flow | 30.28 Million | 18.93 Million | -21.26 Million | -12.96 Million | -53.65 Million | -7.86 Million |
| Investments in PPE | -4.28 Million | -5.86 Million | -17.57 Million | -14.96 Million | -56.03 Million | -8.22 Million |
| Acquisitions | 25.36 Million | 20.78 Million | 707.4 Thousand | 530 Thousand | 361.77 Thousand | 361.77 Thousand |
| Investment purchases | - | -27.19 Million | - | -11.35 Million | -400 Thousand | 1.73 |
| Sales/Maturities of investments | 9.2 Million | 27.23 Million | - | 2.38 Million | 2.39 Million | 15.71 Thousand |
| Other Investing Activities | 25.36 Million | -10.18 Million | -3.97 Million | 1.99 Million | 18.53 Thousand | -9741.10 |
| Financing Cash Flow | -21.71 Million | -2.82 Million | -36.73 Million | -5.41 Million | -200.62 Million | -34.31 Million |
| Debt repayment | -6.7 Million | -2.42 Million | -2.43 Million | -18.68 Million | -59.91 Million | -15.38 Million |
| Dividends payments | -1.86 Million | -30.02 Million | -23.49 Million | -12.38 Million | -140.65 Million | -37.43 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.15 Million | 14.62 Million | -673.67 Thousand | 41.62 Million | 15.9 Million | 18.49 Million |
| Accounts receivables | - | - | - | 62.88 Million | 62.88 Million | 692.63 Thousand |
| Accounts payables | - | - | - | - | -126.51 Million | 1.8 Million |
| Inventory | - | - | - | 9.61 Million | 9.61 Million | 39.15 Million |
| Other working capital | - | - | - | 17.1 Million | 17.1 Million | -1.8 Million |
| Cash at beginning of period | 86.69 Million | 103.03 Million | 135.22 Million | 82.43 Million | 126.37 Million | 85.2 Million |
| Cash at end of period | 65.73 Million | 86.69 Million | 103.03 Million | 135.52 Million | 135.52 Million | 82.43 Million |
| Capital Expenditure | -4.28 Million | -5.86 Million | -17.57 Million | -14.96 Million | -56.03 Million | -8.22 Million |
| Effect of forex changes on cash | -1270.44 | 797.36 | 46.22 | -5199.17 | -3601.53 | -1863.12 |
| Net cash flow / Change in cash | -20.96 Million | -16.33 Million | -32.18 Million | 53.08 Million | 9.15 Million | -2.76 Million |
| Free Cash Flow | -33.81 Million | -38.3 Million | 8.23 Million | 56.5 Million | 207.4 Million | 31.19 Million |
SAABY
603076
GWO-PI
EDTXF
SPOK
FULT